Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methenamine vs Antibiotics for UTI Prophylaxis after MUS
NCT06810687Recruiting
- Sponsor
- Atlantic Health System
- Start
- Jan 2025
- Primary completion
- Jul 2027
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of methenamine hippurate in urinary tract infection (UTI) (2 arms), sponsored by Atlantic Health System. Primary endpoint: Incidence of urinary tract infection at 6 weeks. Started Jan 2025; status: recruiting.
02
Drugs
methenamine hippurate
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT06810687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06810687.